Literature DB >> 20022654

Risk of HCC: genetic heterogeneity and complex genetics.

Tommaso A Dragani1.   

Abstract

Hepatocellular carcinoma (HCC) is a common form of cancer that arises from hepatocytes and whose risk may be affected by several known environmental factors, including hepatitis viruses, alcohol, cigarette smoking, and others. Rare monogenic syndromes, such as alpha1-antitrypsin deficiency, glycogen storage disease type I, hemochromatosis, acute intermittent and cutanea tarda porphyria, as well as hereditary tyrosinemia type I are associated with a high risk of HCC. Several common conditions or diseases inherited as polygenic traits e.g. autoimmune hepatitis, type 2 diabetes, a family history of HCC, hypothyroidism, and non-alcoholic steatohepatitis also show an increased risk of HCC compared to the general population. Overall, the genetic susceptibility to HCC is characterized by a genetic heterogeneity; a high individual risk of HCC may thus be caused by several unlinked single gene defects, whose carriers are rare in the general population, or by more common conditions inherited by complex genetics.

Entities:  

Mesh:

Year:  2009        PMID: 20022654     DOI: 10.1016/j.jhep.2009.11.015

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  75 in total

1.  Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E.

Authors:  Xuetian Yue; Zhenyu Zhang; Xiaohong Liang; Lifen Gao; Xiaoning Zhang; Di Zhao; Xiao Liu; Hongxin Ma; Min Guo; Brett T Spear; Yaoqin Gong; Chunhong Ma
Journal:  Gastroenterology       Date:  2012-03-06       Impact factor: 22.682

2.  Developmental Stage-Specific Hepatocytes Induce Maturation of HepG2 Cells by Rebuilding the Regulatory Circuit.

Authors:  Yanning Li; Demei Liu; Yanhong Zong; Jinsheng Qi; Bin Li; Kun Liu; Hui Xiao
Journal:  Mol Med       Date:  2015-04-14       Impact factor: 6.354

Review 3.  AEG-1/MTDH/LYRIC in liver cancer.

Authors:  Devanand Sarkar
Journal:  Adv Cancer Res       Date:  2013       Impact factor: 6.242

4.  Interactive effect of glutathione S-transferase M1 and T1 polymorphisms on hepatocellular carcinoma.

Authors:  Chengguang Sui; Jianzhong Ma; Xin He; Guang Wang; Fulu Ai
Journal:  Tumour Biol       Date:  2014-05-23

5.  Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.

Authors:  Yue-Li Nan; Yan-Ling Hu; Zhi-Ke Liu; Fang-Fang Duan; Yang Xu; Shu Li; Ting Li; Da-Fang Chen; Xiao-Yun Zeng
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

Review 6.  Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma.

Authors:  Tiffany Hennedige; Sudhakar K Venkatesh
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

7.  p53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies.

Authors:  Xi Chen; Fei Liu; Bo Li; Yong-Gang Wei; Lv-Nan Yan; Tian-Fu Wen
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

Review 8.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

9.  Sequential adaptive changes in a c-Myc-driven model of hepatocellular carcinoma.

Authors:  James M Dolezal; Huabo Wang; Sucheta Kulkarni; Laura Jackson; Jie Lu; Sarangarajan Ranganathan; Eric S Goetzman; Sivakama S Bharathi; Kevin Beezhold; Craig A Byersdorfer; Edward V Prochownik
Journal:  J Biol Chem       Date:  2017-04-21       Impact factor: 5.157

10.  Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.

Authors:  Xiaodong Zhao; Tianyi Wang; Bo Liu; Zhenzhou Wu; Shuo Yu; Tao Wang
Journal:  Tumour Biol       Date:  2014-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.